These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4213765)

  • 21. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa infection and cystic fibrosis.
    Kato K; Takayama T
    Lancet; 2002 Jan; 359(9302):262. PubMed ID: 11812595
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
    Høiby N; Hertz JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
    Döring G
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis.
    Thanasekaraan V; Wiseman MS; Rayner RJ; Hiller EJ; Shale DJ
    Arch Dis Child; 1989 Nov; 64(11):1599-603. PubMed ID: 2513779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
    Diaz E; Mosovich LL; Neter E
    J Infect Dis; 1970 Mar; 121(3):269-74. PubMed ID: 4984335
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective study of serum staphylococcal antibodies in cystic fibrosis.
    Hollsing AE; Granström M; Strandvik B
    Arch Dis Child; 1987 Sep; 62(9):905-11. PubMed ID: 3118820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection.
    Shand GH; Pedersen SS; Brown MR; Høiby N
    J Med Microbiol; 1991 Apr; 34(4):203-12. PubMed ID: 1902261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.
    Speert DP
    Surv Synth Pathol Res; 1985; 4(1):14-33. PubMed ID: 3927464
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
    J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract.
    Kiedrowski MR; Bomberger JM
    Front Immunol; 2018; 9():3067. PubMed ID: 30619379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa allergy in cystic fibrosis. Involvement of histamine release in the pathogenesis of lung tissue damage.
    Skov PS; Norn S; Schiøtz PO; Permin H; Høiby N
    Allergy; 1980 Jan; 35(1):23-9. PubMed ID: 6154430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.
    Fernandes PB; Kim C; Cundy KR; Haung NN
    Infect Immun; 1981 Aug; 33(2):527-32. PubMed ID: 6792080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis and pseudomonas infection.
    Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of infection with Pseudomonas aeruginosa in cystic fibrosis: the Holy Grail or an achievable goal?
    Taccetti G; Sly PD
    J Cyst Fibros; 2014 Sep; 13(5):491-3. PubMed ID: 25156429
    [No Abstract]   [Full Text] [Related]  

  • 39. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
    Holby N
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.